Quick Answer
PTC THERAPEUTICS, INC. reported Net Income Loss of $682.64 million for the year ending 2025.
- PTC THERAPEUTICS, INC. showed an increase of +287.9% in Net Income Loss from 2024 to 2025.
- This data is from PTC THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), PTC THERAPEUTICS, INC.'s Net Income Loss has grown by 2,108.9%.
- Historical annual values: Fiscal year 2025: $682.64 million | Fiscal year 2024: -$363.30 million | Fiscal year 2023: -$626.60 million | Fiscal year 2022: -$559.02 million | Fiscal year 2021: -$523.90 million | Fiscal year 2020: -$438.16 million | Fiscal year 2019: -$251.58 million | Fiscal year 2018: -$128.08 million | Fiscal year 2017: -$79.00 million | Fiscal year 2016: -$142.11 million | Fiscal year 2015: -$170.45 million | Fiscal year 2014: -$93.75 million | Fiscal year 2013: -$51.57 million | Fiscal year 2012: -$26.24 million | Fiscal year 2011: $30.90 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: